Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
268
-
Total shares
-
33.5M
-
Shares change
-
+288K
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
-$571K
-
Put/Call ratio
-
1.01
-
Number of buys
-
130
-
Number of sells
-
-150
-
Price
-
$43.91
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2024
265 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2024.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.5M shares
of 50.5M outstanding shares and own 66.42% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.08M shares), VANGUARD GROUP INC (2.73M shares), FEDERATED HERMES, INC. (2.08M shares), NEUBERGER BERMAN GROUP LLC (1.66M shares), STATE STREET CORP (1.51M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.27M shares), DIMENSIONAL FUND ADVISORS LP (1.18M shares), TD Asset Management Inc (1.01M shares), GEODE CAPITAL MANAGEMENT, LLC (866K shares), and Epoch Investment Partners, Inc. (798K shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.